Sarepta stock rose sharply Tuesday after the Food and Drug Administration allowed the biopharma company to resume shipments ...

A deal with US WorldMeds includes the FDA-approved TCR therapy Tecelra and two clinical-stage cancer medicines.

Shares of drugmaker Sarepta Therapeutics surged in afterhours trading Monday after the company said it would resume shipping its gene therapy ...